Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Ahmed, Z.
space
  arrow  Goldman, J. M.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

LETTER

Reevaluation of Amiodarone

right arrow Zia Ahmed, MD, and Joel M. Goldman, MD

15 November 1995 | Volume 123 Issue 10 | Page 809


TO THE EDITOR:

In his comprehensive review of amiodarone, Dr. Podrid [1] discusses minor thyroid abnormalities, particularly the elevation of thyroid-stimulating hormone (TSH) levels. He does not mention the more common and more problematic elevation in thyroxine levels. Elevation of TSH levels is only transient, and levels gradually return to pretreatment values [2, 3]. In contrast, thyroxine and free thyroxine levels remain elevated [2, 3]. This condition can be confused with hyperthyroidism, which also occurs in a few patients receiving amiodarone. It can be difficult to distinguish between a euthyroid patient receiving amiodarone and an amiodarone-treated patient who has become hyperthyroid [3, 4]. Ultrasensitive TSH assays and measurement of triiodothyronine and free triiodothyronine levels can be useful in this setting [3, 4].


Author and Article Information
space
up arrowTop
dotAuthor & Article Info
down arrowReferences

Brookdale Hospital Medical Center; Brooklyn, NY 11212


References
space
up arrowTop
up arrowAuthor & Article Info
dotReferences

1. Podrid PJ. Amiodarone: reevaluation of an old drug. Ann Intern Med. 1995; 122:689-700.

2. Nademanee K, Piwonka RW, Singh BN, Hershman JM. Amiodarone and thyroid function. Prog Cardiovasc Dis. 1989; 31:427-37.

3. Wiersinga WM, Trip MD. Amiodarone and thyroid hormone metabolism. Postgrad Med J. 1986; 62:909-14.

4. Lombardi A, Martino E, Braverman LE. Amiodarone and the thyroid. Thyroid Today. 1990; 13:1-7.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.





box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Ahmed, Z.
space
  arrow  Goldman, J. M.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online